The global xylooligosaccharide (XOS) market is projected to grow from USD 44.3 million in 2026 to USD 79.6 million by 2036, registering a compound annual growth rate (CAGR) of 6.1%, according to Future Market Insights (FMI). The forecast represents an increase of USD 35.3 million over the period.
Get detailed market forecasts, competitive benchmarking, and pricing trends:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14247
XOS is used as a prebiotic ingredient in livestock and pet nutrition. FMI estimates that dry products will account for 69.7% of form-market share in 2026, while livestock applications will represent 64.3% of product-type demand. Powder formats can be incorporated into existing feed-premix processes, making handling compatibility an important consideration for manufacturers evaluating new ingredients.
Feed-industry demand puts production economics in focus
Feed manufacturers are evaluating prebiotic ingredients as part of efforts to develop non-antibiotic approaches to animal nutrition. A review published in Food, Nutrition and Health on June 22, 2026, discussed the prebiotic potential of XOS, its applications in animal feed and the remaining challenges associated with industrial production.
The review identified agro-industrial waste as a potential route to reducing feedstock costs, while highlighting the challenge of achieving high-purity products at high industrial yields. These production considerations matter because XOS competes with established feed ingredients on formulation economics as well as performance.
FMI estimates that the animal feed prebiotics market will grow from USD 2,407.9 million in 2026 to USD 3,922.2 million by 2036, at a CAGR of 5.0%. The eubiotic feed additives market is projected to reach USD 10,651.1 million by 2036, while the pet gut health supplements market is forecast to expand at a 9.6% CAGR over its stated forecast period.
Where growth is fastest
Japan is projected to record the fastest growth among the eight countries profiled by FMI between 2026 and 2036.
- Japan — 7.8% CAGR: Feed-additive designation requires evidence of necessity, effectiveness and safety. Suppliers with appropriate documentation and local trial data may be better positioned to navigate the approval process.
- Canada — 6.8% CAGR: FMI links the outlook to livestock inventories and opportunities for recurring premix demand.
- United States — 5.7% CAGR: Feed-efficiency considerations are relevant to producers managing production costs and animal output.
- United Kingdom — 5.3% CAGR: Growth in poultry production supports opportunities for powdered additives that can move through established compound-feed processes.
- Germany — 5.0% CAGR: Larger average pig-herd sizes concentrate purchasing activity, potentially increasing the volume affected by an individual feed-formula decision.
- France — 4.4% CAGR: Demand is linked to productivity requirements in established pig and poultry sectors.
- Italy — 4.1% CAGR: FMI’s forecast reflects a more moderate growth outlook than Japan’s.
- Russia — 3.7% CAGR: Greater reliance on established gut-health products and price-led feed formulations is expected to constrain growth relative to the other profiled countries.
What leads the market
Two segments account for the leading projected shares of the XOS market in 2026, according to FMI.
- Dry products — 69.7%: Powder grades can be incorporated into existing premix and compound-feed systems. They also avoid the additional freight cost associated with transporting water in liquid formulations.
- Livestock applications — 64.3%: Poultry and swine feed programs offer repeated ingredient use across large volumes of compound feed, supporting demand for suitable XOS grades.
FMI also cites a September 2025 study in Frontiers in Veterinary Science examining XOS supplementation in weaning pigs. The report states that a dosage of 500 mg/kg lowered the feed-to-gain ratio by 5.1% and increased ileal villus height by 11.6% in the study.
The hurdle: cost, approvals and evidence
The principal commercial challenge is converting promising ingredient research into repeat purchases at a competitive cost. Enzymatic hydrolysis and biomass pretreatment can add to production expenses, while feed-additive rules and species-specific trials can extend the time required to qualify a product.
Feed manufacturers also need evidence relevant to their intended use. Performance in one species or feeding program does not automatically establish the same outcome in another. Ingredient consistency, inclusion rates and compatibility with existing formulations must be assessed as part of the qualification process.
Recent developments and industry investment
Recent developments in the wider functional-ingredient and animal-nutrition sectors illustrate investment in product verification, production capabilities and specialized premix infrastructure.
- February 3, 2026: Roquette announced NutraStrong Prebiotic Verified certification from SGS Nutrasource for its NUTRIOSE FM 06, FB 06 and FM 15S soluble-fiber products. The development concerns soluble fibers and should not be interpreted as XOS-specific certification.
- February 9, 2026: DSM-Firmenich announced an agreement to divest its Animal Nutrition & Health business to CVC Capital Partners at an enterprise value of EUR 2.2 billion, with closing expected by the end of 2026.
- May 11, 2026: DSM-Firmenich announced the opening of NextGen Itatiba in São Paulo state, Brazil, a premix facility dedicated to pet nutrition and producing vitamin and mineral premixes for cats and dogs.
FMI identifies the following companies among the notable participants in the xylooligosaccharide market: Shandong Longlive Bio-Technology Co., Ltd., Baolingbao Biology Co., Ltd., Shandong Bailong Chuangyuan Bio-Tech Co., Ltd., COFCO Biotechnology Co., Ltd., DSM-Firmenich and Roquette Frères.
Competition spans direct XOS manufacturers, functional-sugar producers with feed-related businesses, and broader animal-nutrition and fiber suppliers. Product documentation, production scale, formulation compatibility and technical evidence are important considerations for buyers evaluating suppliers.
Analyst perspective
“Xylooligosaccharide will grow fastest as a low-dose gut health additive in livestock and pet nutrition, as feed makers are looking for proven alternatives to antibiotic growth promoters. The biggest opportunity lies in dry, heat-stable grades backed by species-specific trial data, as poultry, swine and premium pet food producers will pay for measurable gains in gut health and feed efficiency.” — Nandini Roy Choudhury, Principal Consultant, Future Market Insights
What this means for feed manufacturers and ingredient buyers
- Compare total formulation cost, not ingredient price alone. Evaluate feedstock costs, refining yield, transport, inclusion rates and compatibility with existing premix lines. These factors help determine whether an XOS grade is commercially viable at the intended production scale.
- Request evidence relevant to the target species. Review feeding-trial design, dosage, ingredient specifications and measured outcomes before approving a new product. Results from poultry or swine research should not automatically be applied to other animals.
- Check documentation before expanding procurement. Confirm the applicable feed-additive requirements in the destination market and obtain the technical information needed for supplier qualification. For pet-nutrition applications, assess whether the ingredient and formulation fit the intended product and applicable requirements.
For detailed market forecasts, form and product-type shares, country-level growth rates and competitive analysis, read Future Market Insights’ Xylooligosaccharide Market Report:
https://www.futuremarketinsights.com/reports/xylooligosaccharide-market
Explore More Research Reports by FMI
Galacto-Oligosaccharide Market –
https://www.futuremarketinsights.com/reports/galacto-oligosaccharide-gos-market
Xylooligosaccharide Market –
https://www.futuremarketinsights.com/reports/xylooligosaccharide-market
Natural Vanilla & Sustainable Flavor Sourcing Market –
https://www.newstrail.com/natural-vanilla-sustainable-flavor-sourcing-market/
About Future Market Insights (FMI)
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.
For Press & Corporate Inquiries
Rahul Singh AVP – Marketing and Growth Strategy
Future Market Insights, Inc.
+91 8600020075
For Sales: sales@futuremarketinsights.com
For Media: Rahul.singh@futuremarketinsights.com
For Web: https://www.futuremarketinsights.com/